ArticleFrontiers in oncology2026

Risk-adapted use of thoracic radiotherapy in stage IV non-small cell lung cancer: a multicenter prognostic model study.

Jiaxing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.